To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

ChemoBrain or ChemoFog

Posted 5/5/2011

Posted in

This is a disheartening article from the Journal of Pain and Symptom Management about the long term effects of chemobrain--that is the possible cognitive implications of receiving chemotherapy. Like everything else, there is huge variability in this issue, and I have known very few people who felt that they were truly damaged or disadvantaged intellectually. For most of us, it is worst during active treatment when it is easy to understand a drug fog. And then, over time, there may be moments of "why did I come into this room?" or trouble with names or, sometimes, word finding. We manage, and it is impossible to tease out how it might be different with normal aging (and, especially for women, with diminished estrogen).

Anyway, here is the summary and then a link to read more:

Either Called "Chemobrain" or "Chemofog," the

Long-Term Chemotherapy-Induced Cognitive

Decline in Cancer Survivors Is Real

Andreas A. Argyriou, MD, PhDac, Konstantinos Assimakopoulos, MD,

PhDb, Gregoris Iconomou, PhDc, Fotini Giannakopoulou, MDc,

Haralabos P. Kalofonos, MD, PhDc

Accepted 21 April 2010. published online 14 September 2010.

Abstract


In recent years, there is growing evidence in the medical literature

to support an association between administration of commonly

used chemotherapeutic agents and an increased risk for cognitive

impairment.

Objectives

We herein critically summarize data relating to the

pathophysiological mechanisms by which chemotherapy may

induce cognitive impairment in patients surviving from solid tumors.

The clinical and epidemiological characteristics and the proposed

management strategies to counter chemotherapy-induced cognitive

impairment (CICI) also are presented.

Methods

References for this review were identified by searches of PubMed

from 1995 until December 2009 with related terms.

Results

Both the pathogenetic mechanisms and the overall clinical nature

of CICI remain vaguely defined. Findings indicate that CICI is a

relatively common event that, in most of the cases, remains

underdiagnosed, thereby adversely affecting the quality of life of

patients with cancer. Effective pharmacological interventions toward

the symptomatic or prophylactic management of CICI also are

lacking.

Conclusion

Either called "chemobrain" or "chemofog," the long-term CICI in

cancer survivors is real. The need for multidisciplinary care

interventions toward a timely diagnosis and management of CICI is

clearly warranted.

http://tinyurl.com/4te6mlx

Share:

Add your comment

 
 
 

Categories

Archive